Skip to main content
Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Published Web Location
http://europepmc.org/articles/PMC3824937?pdf=renderNo data is associated with this publication.
Abstract
Purpose: This study was designed to determine (1) rates of clinically meaningful tumor reduction in breast tumor size following neoadjuvant chemotherapy (NAC), (2) which receptor subtypes and MRI phenotypes are associated with clinically meaningful tumor r
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.